Search research articles
Contact Us
Filters
Showing results (31-40 of 59) with videos related to
Page
of 6
Sort By:
Obesity Surgery
|
August 10, 2020
Reversal of Roux-en-Y Gastric Bypass Fails to Facilitate the Management of Recalcitrant Hypocalcaemia Caused by Primary Hypoparathyroidism
Katrien Corbeels, Nele Steenackers, Matthias Lannoo, et al.
Acta Clinica Belgica
|
May 5, 2016
Long-term effects of gastric bypass surgery on psychosocial well-being and eating behavior: not all that glitters is gold
Roman Vangoitsenhoven, Pascal Frederiks, Brecht Gijbels, et al.
International Journal of Obesity (2005)
|
June 18, 2020
The curious fate of bone following bariatric surgery: bone effects of sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) in mice
Katrien Corbeels, Lieve Verlinden, Matthias Lannoo, et al.
Nutrition and Health
|
April 3, 2023
Change in carbohydrate intake one year after Roux-en-Y gastric bypass: A prospective study
Joke Vliebergh, Ina Gesquiere, Veerle Foulon, et al.
Scientific Reports
|
April 8, 2024
Comparative impact of Roux-en-Y gastric bypass, sleeve gastrectomy or diet alone on beta-cell function in insulin-treated type 2 diabetes patients
Matthias Lannoo, Caroline Simoens, Roman Vangoitsenhoven, et al.
Frontiers in Endocrinology
|
June 1, 2026
Case Report: Twenty years of metreleptin therapy in congenital generalized lipodystrophy type 1: the longest reported follow-up to date
Elise Van der Borght, Bart Van der Schueren, Roman Vangoitsenhoven, et al.
Scientific Reports
|
April 14, 2018
Unraveling the compromised biomechanical performance of type 2 diabetes- and Roux-en-Y gastric bypass bone by linking mechanical-structural and physico-chemical properties
Carlos Marin, Georgios Papantonakis, Kathleen Sels, et al.
Plos One
|
August 15, 2014
Foodborne cereulide causes beta-cell dysfunction and apoptosis
Roman Vangoitsenhoven, Dieter Rondas, Inne Crèvecoeur, et al.
Bone Research
|
February 10, 2026
Pharmacological HIF activation protects against diet-induced obesity, glucose intolerance, and skeletal dysfunction by exerting dual beneficial effects on energy metabolism and bone
Roger Valle-Tenney, Nicolas Peredo, Karen De Samblancx, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
May 28, 2025
A dietary intervention following incretin analog treatment restores adipose tissue functions in diet-induced obese mice
Joke Seuntjens, Jente De Gols, Bethan K Davies, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 59) with videos related to
Sort By:
Page
of 6
Obesity Surgery
|
August 10, 2020
Reversal of Roux-en-Y Gastric Bypass Fails to Facilitate the Management of Recalcitrant Hypocalcaemia Caused by Primary Hypoparathyroidism
Katrien Corbeels, Nele Steenackers, Matthias Lannoo, et al.
Acta Clinica Belgica
|
May 5, 2016
Long-term effects of gastric bypass surgery on psychosocial well-being and eating behavior: not all that glitters is gold
Roman Vangoitsenhoven, Pascal Frederiks, Brecht Gijbels, et al.
International Journal of Obesity (2005)
|
June 18, 2020
The curious fate of bone following bariatric surgery: bone effects of sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) in mice
Katrien Corbeels, Lieve Verlinden, Matthias Lannoo, et al.
Nutrition and Health
|
April 3, 2023
Change in carbohydrate intake one year after Roux-en-Y gastric bypass: A prospective study
Joke Vliebergh, Ina Gesquiere, Veerle Foulon, et al.
Scientific Reports
|
April 8, 2024
Comparative impact of Roux-en-Y gastric bypass, sleeve gastrectomy or diet alone on beta-cell function in insulin-treated type 2 diabetes patients
Matthias Lannoo, Caroline Simoens, Roman Vangoitsenhoven, et al.
Frontiers in Endocrinology
|
June 1, 2026
Case Report: Twenty years of metreleptin therapy in congenital generalized lipodystrophy type 1: the longest reported follow-up to date
Elise Van der Borght, Bart Van der Schueren, Roman Vangoitsenhoven, et al.
Scientific Reports
|
April 14, 2018
Unraveling the compromised biomechanical performance of type 2 diabetes- and Roux-en-Y gastric bypass bone by linking mechanical-structural and physico-chemical properties
Carlos Marin, Georgios Papantonakis, Kathleen Sels, et al.
Plos One
|
August 15, 2014
Foodborne cereulide causes beta-cell dysfunction and apoptosis
Roman Vangoitsenhoven, Dieter Rondas, Inne Crèvecoeur, et al.
Bone Research
|
February 10, 2026
Pharmacological HIF activation protects against diet-induced obesity, glucose intolerance, and skeletal dysfunction by exerting dual beneficial effects on energy metabolism and bone
Roger Valle-Tenney, Nicolas Peredo, Karen De Samblancx, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
May 28, 2025
A dietary intervention following incretin analog treatment restores adipose tissue functions in diet-induced obese mice
Joke Seuntjens, Jente De Gols, Bethan K Davies, et al.
Page
of 6